497 related articles for article (PubMed ID: 32943608)
1. Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer.
Charan M; Das S; Mishra S; Chatterjee N; Varikuti S; Kaul K; Misri S; Ahirwar DK; Satoskar AR; Ganju RK
Cell Death Dis; 2020 Sep; 11(9):774. PubMed ID: 32943608
[TBL] [Abstract][Full Text] [Related]
2. MIF antagonist (CPSI-1306) protects against UVB-induced squamous cell carcinoma.
Nagarajan P; Tober KL; Riggenbach JA; Kusewitt DF; Lehman AM; Sielecki T; Pruitt J; Satoskar AR; Oberyszyn TM
Mol Cancer Res; 2014 Sep; 12(9):1292-302. PubMed ID: 24850900
[TBL] [Abstract][Full Text] [Related]
3. Autophagy inhibition in breast cancer cells induces ROS-mediated MIF expression and M1 macrophage polarization.
Cotzomi-Ortega I; Nieto-Yañez O; Juárez-Avelar I; Rojas-Sanchez G; Montes-Alvarado JB; Reyes-Leyva J; Aguilar-Alonso P; Rodriguez-Sosa M; Maycotte P
Cell Signal; 2021 Oct; 86():110075. PubMed ID: 34229086
[TBL] [Abstract][Full Text] [Related]
4. MIF as a potential diagnostic and prognostic biomarker for triple-negative breast cancer that correlates with the polarization of M2 macrophages.
Chen M; Liu H; Hong B; Xiao Y; Qian Y
FASEB J; 2024 May; 38(10):e23696. PubMed ID: 38787620
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
[TBL] [Abstract][Full Text] [Related]
6. The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer.
Thies KA; Cole MW; Schafer RE; Spehar JM; Richardson DS; Steck SA; Das M; Lian AW; Ray A; Shakya R; Knoblaugh SE; Timmers CD; Ostrowski MC; Chakravarti A; Sizemore GM; Sizemore ST
Breast Cancer Res; 2021 Jun; 23(1):65. PubMed ID: 34118960
[TBL] [Abstract][Full Text] [Related]
7. Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer.
Xiang L; Gilkes DM; Chaturvedi P; Luo W; Hu H; Takano N; Liang H; Semenza GL
J Mol Med (Berl); 2014 Feb; 92(2):151-64. PubMed ID: 24248265
[TBL] [Abstract][Full Text] [Related]
8. PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer.
Yu TJ; Liu YY; Li XG; Lian B; Lu XX; Jin X; Shao ZM; Hu X; Di GH; Jiang YZ
Cancer Res; 2021 Nov; 81(21):5491-5505. PubMed ID: 34408002
[TBL] [Abstract][Full Text] [Related]
9. Macrophage migration inhibitory factor is regulated by HIF-1α and cAMP and promotes renal cyst cell proliferation in a macrophage-independent manner.
Safi W; Kraus A; Grampp S; Schödel J; Buchholz B
J Mol Med (Berl); 2020 Nov; 98(11):1547-1559. PubMed ID: 32885302
[TBL] [Abstract][Full Text] [Related]
10. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.
Kabil N; Bayraktar R; Kahraman N; Mokhlis HA; Calin GA; Lopez-Berestein G; Ozpolat B
Breast Cancer Res Treat; 2018 Oct; 171(3):593-605. PubMed ID: 29971628
[TBL] [Abstract][Full Text] [Related]
11. Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple-negative breast cancer.
Alraouji NN; Al-Mohanna FH; Ghebeh H; Arafah M; Almeer R; Al-Tweigeri T; Aboussekhra A
Mol Carcinog; 2020 Sep; 59(9):1041-1051. PubMed ID: 32537818
[TBL] [Abstract][Full Text] [Related]
12. Novel inhibitors of macrophage migration inhibitory factor prevent cytokine-induced beta cell death.
Vujicic M; Nikolic I; Krajnovic T; Cheng KF; VanPatten S; He M; Stosic-Grujicic S; Stojanovic I; Al-Abed Y; Saksida T
Eur J Pharmacol; 2014 Oct; 740():683-9. PubMed ID: 24967533
[TBL] [Abstract][Full Text] [Related]
13. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.
Ring A; Kaur P; Lang JE
BMC Cancer; 2020 Nov; 20(1):1076. PubMed ID: 33167919
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
Xu X; Wang B; Ye C; Yao C; Lin Y; Huang X; Zhang Y; Wang S
Cancer Lett; 2008 Mar; 261(2):147-57. PubMed ID: 18171602
[TBL] [Abstract][Full Text] [Related]
15. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.
Woodcock CC; Huang Y; Woodcock SR; Salvatore SR; Singh B; Golin-Bisello F; Davidson NE; Neumann CA; Freeman BA; Wendell SG
J Biol Chem; 2018 Jan; 293(4):1120-1137. PubMed ID: 29158255
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor siRNA inhibits hepatic metastases of colorectal cancer cells.
Wu LH; Xia HH; Ma WQ; Zhong HJ; Xu HX; Wang YM; Yang RJ; Wang LJ; Chen Y; Li L; He XX
Front Biosci (Landmark Ed); 2017 Mar; 22(8):1365-1378. PubMed ID: 28199208
[TBL] [Abstract][Full Text] [Related]
17. Mifepristone Suppresses Basal Triple-Negative Breast Cancer Stem Cells by Down-regulating KLF5 Expression.
Liu R; Shi P; Nie Z; Liang H; Zhou Z; Chen W; Chen H; Dong C; Yang R; Liu S; Chen C
Theranostics; 2016; 6(4):533-44. PubMed ID: 26941846
[TBL] [Abstract][Full Text] [Related]
18. PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis.
Paul A; Gunewardena S; Stecklein SR; Saha B; Parelkar N; Danley M; Rajendran G; Home P; Ray S; Jokar I; Vielhauer GA; Jensen RA; Tawfik O; Paul S
Cell Death Differ; 2014 Sep; 21(9):1469-81. PubMed ID: 24786829
[TBL] [Abstract][Full Text] [Related]
19. Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells.
Baron N; Deuster O; Noelker C; Stüer C; Strik H; Schaller C; Dodel R; Meyer B; Bacher M
J Neurosci Res; 2011 May; 89(5):711-7. PubMed ID: 21360573
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer.
Lee J; Lim B; Pearson T; Choi K; Fuson JA; Bartholomeusz C; Paradiso LJ; Myers T; Tripathy D; Ueno NT
Breast Cancer Res Treat; 2019 Jun; 175(2):339-351. PubMed ID: 30826934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
